Federated Hermes Inc. Grows Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)

Federated Hermes Inc. boosted its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 39.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 176,232 shares of the medical instruments supplier's stock after purchasing an additional 50,265 shares during the quarter. Federated Hermes Inc. owned approximately 0.73% of ICU Medical worth $17,577,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. M&T Bank Corp raised its holdings in ICU Medical by 5.4% in the third quarter. M&T Bank Corp now owns 4,661 shares of the medical instruments supplier's stock worth $555,000 after purchasing an additional 239 shares in the last quarter. Knights of Columbus Asset Advisors LLC increased its holdings in shares of ICU Medical by 16.7% during the third quarter. Knights of Columbus Asset Advisors LLC now owns 1,848 shares of the medical instruments supplier's stock valued at $220,000 after acquiring an additional 264 shares in the last quarter. Gamco Investors INC. ET AL increased its holdings in shares of ICU Medical by 1.1% during the third quarter. Gamco Investors INC. ET AL now owns 24,950 shares of the medical instruments supplier's stock valued at $2,969,000 after acquiring an additional 278 shares in the last quarter. Private Trust Co. NA increased its holdings in shares of ICU Medical by 1,428.6% during the third quarter. Private Trust Co. NA now owns 321 shares of the medical instruments supplier's stock valued at $38,000 after acquiring an additional 300 shares in the last quarter. Finally, Daiwa Securities Group Inc. increased its holdings in shares of ICU Medical by 1.2% during the fourth quarter. Daiwa Securities Group Inc. now owns 28,612 shares of the medical instruments supplier's stock valued at $2,854,000 after acquiring an additional 350 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

ICU Medical Stock Performance

NASDAQ:ICUI traded up $1.38 on Tuesday, hitting $97.76. The stock had a trading volume of 160,278 shares, compared to its average volume of 255,132. The stock has a market cap of $2.38 billion, a price-to-earnings ratio of -79.48 and a beta of 0.69. The company has a quick ratio of 1.06, a current ratio of 2.53 and a debt-to-equity ratio of 0.74. The business's 50-day simple moving average is $102.12 and its two-hundred day simple moving average is $98.06. ICU Medical, Inc. has a 52-week low of $78.28 and a 52-week high of $212.43.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.39. The business had revenue of $587.86 million for the quarter, compared to analysts' expectations of $564.77 million. ICU Medical had a positive return on equity of 6.35% and a negative net margin of 1.31%. As a group, research analysts predict that ICU Medical, Inc. will post 3.52 earnings per share for the current year.

Insiders Place Their Bets

In related news, VP Daniel Woolson sold 791 shares of the business's stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $98.27, for a total transaction of $77,731.57. Following the completion of the transaction, the vice president now directly owns 13,980 shares in the company, valued at approximately $1,373,814.60. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, COO Christian B. Voigtlander sold 13,603 shares of the business's stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $107.19, for a total value of $1,458,105.57. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Daniel Woolson sold 791 shares of the business's stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the transaction, the vice president now directly owns 13,980 shares in the company, valued at $1,373,814.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 24,262 shares of company stock valued at $2,545,532. Insiders own 6.70% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, KeyCorp raised their price target on ICU Medical from $134.00 to $136.00 and gave the company an "overweight" rating in a report on Wednesday, February 28th. One research analyst has rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $123.00.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.